Latest Production News

Tungsten Mining NL (ASX, TGN) reinforces its position as a leading tungsten resource holder outside China, unveiling a robust development strategy aligned with soaring global demand and supply constraints.

Black Cat Syndicate has locked in ore purchase agreements to boost processing at Lakewood, supporting the ramp-up of its Fingals and Majestic mines under its More Gold, Sooner strategy.

Rio Tinto reported robust third quarter 2025 production results, highlighted by record outputs in bauxite and copper, and an upgraded bauxite production forecast. Key projects like Simandou and Oyu Tolgoi continue to progress on schedule, underpinning the company’s growth trajectory.

Pacific Edge reports a 9% decline in Cxbladder test volumes amid Medicare coverage loss but gains momentum with new clinical validation and a CMS pricing boost.

Amplitude Energy has successfully closed a $150 million equity raising, including a $19 million retail entitlement offer, positioning the company to expand its East Coast Supply Project and potentially restart the Patricia Baleen project.

Magnum Mining & Exploration has raised $7 million through an oversubscribed placement to accelerate its critical minerals processing hub in Nevada and expand rare earth exploration in Brazil, aligning with US strategic priorities.

Manuka Resources has addressed ASX queries about its recent share price and volume spike, attributing the movement to soaring gold and silver prices and its planned production restart in early 2026.

Latrobe Magnesium Limited (ASX – LMG) has launched an $8 million equity raising to fund the ramp-up of its magnesium metal production and advance feasibility studies for a larger commercial plant. The company’s patented hydromet process converts brown coal ash into sustainable magnesium with significantly lower emissions than global peers.

Latrobe Magnesium has locked in $10 million through a placement and entitlement offer to complete its demonstration plant and push towards commercial-scale magnesium production.

Clime Investment Management has completed a $2.3 million placement and announced a bonus option issue, positioning itself for growth as the Australian wealth management sector consolidates.

Cryosite Limited reports a strong start to FY26 with a 22% revenue increase and a strategic warehouse acquisition that doubles capacity, positioning the company for sustained growth in clinical trial logistics.

INOVIQ Limited has launched an A$11.5 million capital raise to fast-track clinical validation and commercialization of its ovarian cancer screening test and advance its CAR-exosome therapeutic program targeting solid tumors.